1. Home
  2. PSTV vs WAFU Comparison

PSTV vs WAFU Comparison

Compare PSTV & WAFU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PSTV
  • WAFU
  • Stock Information
  • Founded
  • PSTV 1996
  • WAFU 1999
  • Country
  • PSTV United States
  • WAFU China
  • Employees
  • PSTV N/A
  • WAFU N/A
  • Industry
  • PSTV Medical/Dental Instruments
  • WAFU Other Consumer Services
  • Sector
  • PSTV Health Care
  • WAFU Real Estate
  • Exchange
  • PSTV Nasdaq
  • WAFU Nasdaq
  • Market Cap
  • PSTV 9.9M
  • WAFU 8.4M
  • IPO Year
  • PSTV N/A
  • WAFU 2019
  • Fundamental
  • Price
  • PSTV $1.74
  • WAFU $1.96
  • Analyst Decision
  • PSTV Strong Buy
  • WAFU
  • Analyst Count
  • PSTV 1
  • WAFU 0
  • Target Price
  • PSTV $8.00
  • WAFU N/A
  • AVG Volume (30 Days)
  • PSTV 57.2K
  • WAFU 8.8K
  • Earning Date
  • PSTV 08-12-2024
  • WAFU 01-01-0001
  • Dividend Yield
  • PSTV N/A
  • WAFU N/A
  • EPS Growth
  • PSTV N/A
  • WAFU N/A
  • EPS
  • PSTV N/A
  • WAFU 0.06
  • Revenue
  • PSTV $6,084,000.00
  • WAFU $8,887,515.00
  • Revenue This Year
  • PSTV $5.21
  • WAFU N/A
  • Revenue Next Year
  • PSTV N/A
  • WAFU N/A
  • P/E Ratio
  • PSTV N/A
  • WAFU $31.67
  • Revenue Growth
  • PSTV 733.42
  • WAFU N/A
  • 52 Week Low
  • PSTV $0.97
  • WAFU $1.58
  • 52 Week High
  • PSTV $3.21
  • WAFU $2.85
  • Technical
  • Relative Strength Index (RSI)
  • PSTV 47.37
  • WAFU 51.67
  • Support Level
  • PSTV $1.70
  • WAFU $1.87
  • Resistance Level
  • PSTV $2.07
  • WAFU $2.00
  • Average True Range (ATR)
  • PSTV 0.17
  • WAFU 0.06
  • MACD
  • PSTV 0.03
  • WAFU -0.01
  • Stochastic Oscillator
  • PSTV 50.75
  • WAFU 47.37

About PSTV PLUS THERAPEUTICS Inc.

Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).

About WAFU Wah Fu Education Group Limited

Wah Fu Education Group Ltd is involved in providing online exam preparation services and related technology solutions and also produces online training course materials in China. It develops online educational materials that are offered through the cloud and that can be used for a wide range of purposes, such as standard examination preparation, professional training, and interactive programs for educational purposes other than exam preparation. Its segments are Online Education Services, and Technological Development and Operation Service. The company generates maximum revenue from the Online Education Services segment.

Share on Social Networks: